EVMNEvommune, Inc.
- Market cap
- $185.09M
- as of 2026-10-23
- Latest close
- $5.10
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2025-11-07
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Pena Luis C.President & CEO | Sep 30 | Oct 15 | A | 1,115 | $7.02 | $7,827 | 631,573 | No | Form 4 |
| Carver KyleChief Financial Officer | Jul 8 | Jul 10 | P | 1,000 | $13.26 | Purchase +$13,260 | 60,335 | No | Form 4 |
| Kirsch Arthur S | Jul 7 | Jul 8 | P | 10,000 | $13.30 | Purchase +$133,000 | 10,000 | No | Form 4 |
| Pena Luis C.President & CEO | Jun 22 | Jun 24 | S | 7,438 | $22.71 | Sale −$168,917 | 630,458 | Yes | Form 4 |
| Drew Janice SuzannChief of Dev. Operations | Jun 22 | Jun 24 | M | 3,839 | $3.84 | $14,742 | 71,633 | Yes | Form 4 |
| Drew Janice SuzannChief of Dev. Operations | Jun 22 | Jun 24 | M | 16,161 | $2.99 | $48,321 | 87,794 | Yes | Form 4 |
| Drew Janice SuzannChief of Dev. Operations | Jun 22 | Jun 24 | S | 20,000 | $22.63 | Sale −$452,600 | 67,794 | Yes | Form 4 |
| Drew Janice SuzannChief of Dev. Operations | Jun 22 | Jun 24 | M · derivative | 3,839 | $3.84 | $14,742 | 53,795 | Yes | Form 4 |
| Drew Janice SuzannChief of Dev. Operations | Jun 22 | Jun 24 | M · derivative | 16,161 | $2.99 | $48,321 | 39,321 | Yes | Form 4 |
| Patel Jeegar PravinkumarChief Scientific Officer | Jun 22 | Jun 24 | M | 1,488 | $3.84 | $5,714 | 47,891 | Yes | Form 4 |
| Patel Jeegar PravinkumarChief Scientific Officer | Jun 22 | Jun 24 | S | 1,488 | $22.50 | Sale −$33,480 | 46,403 | Yes | Form 4 |
| Patel Jeegar PravinkumarChief Scientific Officer | Jun 22 | Jun 24 | M · derivative | 1,488 | $3.84 | $5,714 | 27,842 | Yes | Form 4 |
| Mcgraw Benjamin F III | Jun 2 | Jun 3 | A · derivative | 15,673 | $19.82 | $310,639 | 15,673 | No | Form 4 |
| Kirsch Arthur S | Jun 2 | Jun 3 | A · derivative | 15,673 | $19.82 | $310,639 | 15,673 | No | Form 4 |
| Cohen David E | Jun 2 | Jun 3 | S | 5,456 | $20.21 | Sale −$110,266 | 18,209 | Yes | Form 4 |
| Cohen David E | Jun 2 | Jun 3 | S | 600 | $21.38 | Sale −$12,828 | 17,609 | Yes | Form 4 |
| Cohen David E | Jun 2 | Jun 3 | A · derivative | 15,673 | $19.82 | $310,639 | 15,673 | Yes | Form 4 |
| Pena Luis C.President & CEO | Jun 1 | Jun 3 | S | 16,787 | $22.74 | Sale −$381,736 | 637,896 | Yes | Form 4 |
| Patel Jeegar PravinkumarChief Scientific Officer | Jun 1 | Jun 3 | M | 13,512 | $3.84 | $51,886 | 63,090 | Yes | Form 4 |
| Patel Jeegar PravinkumarChief Scientific Officer | Jun 1 | Jun 3 | S | 16,687 | $22.74 | Sale −$379,462 | 46,403 | Yes | Form 4 |
| Patel Jeegar PravinkumarChief Scientific Officer | Jun 1 | Jun 3 | M · derivative | 13,512 | $3.84 | $51,886 | 29,330 | Yes | Form 4 |
| Moss Gregory S.Chief Business & Legal Officer | May 28 | Jun 1 | M | 14,223 | $1.71 | $24,321 | 75,058 | Yes | Form 4 |
| Moss Gregory S.Chief Business & Legal Officer | May 28 | Jun 1 | S | 14,223 | $22.83 | Sale −$324,711 | 60,835 | Yes | Form 4 |
| Moss Gregory S.Chief Business & Legal Officer | May 28 | Jun 1 | M · derivative | 14,223 | $1.71 | $24,321 | 47,845 | Yes | Form 4 |
| Carver KyleChief Financial Officer | May 28 | Jun 1 | M | 15,000 | $2.99 | $44,850 | 77,510 | Yes | Form 4 |
| Carver KyleChief Financial Officer | May 28 | Jun 1 | S | 18,175 | $22.84 | Sale −$415,117 | 59,335 | Yes | Form 4 |
| Carver KyleChief Financial Officer | May 28 | Jun 1 | M · derivative | 15,000 | $2.99 | $44,850 | 96,731 | Yes | Form 4 |
| Pena Luis C.President & CEO | Apr 16 | Apr 17 | A · derivative | 291,420 | $26.77 | $7,801,313 | 291,420 | No | Form 4 |
| Bauer EugeneChief Medical Officer | Apr 16 | Apr 17 | A · derivative | 51,117 | $26.77 | $1,368,402 | 51,117 | No | Form 4 |
| Moss Gregory S.Chief Business & Legal Officer | Apr 16 | Apr 17 | A · derivative | 115,279 | $26.77 | $3,086,019 | 115,279 | No | Form 4 |
| Carver KyleChief Financial Officer | Apr 16 | Apr 17 | A · derivative | 98,946 | $26.77 | $2,648,784 | 98,946 | No | Form 4 |
| Drew Janice SuzannChief of Dev. Operations | Apr 16 | Apr 17 | A · derivative | 73,892 | $26.77 | $1,978,089 | 73,892 | No | Form 4 |
| Patel Jeegar PravinkumarChief Scientific Officer | Apr 16 | Apr 17 | A · derivative | 69,315 | $26.77 | $1,855,563 | 69,315 | No | Form 4 |
| LSP 7 Cooperative UA | Feb 17 | Feb 19 | A | 358,680 | $27.88 | $9,999,998 | 5,288,313 | No | Form 4 |
| Verduyn-van Weegen Felice Isabel | Feb 17 | Feb 18 | A | 358,680 | $27.88 | $9,999,998 | 5,288,313 | No | Form 4 |
| RA Capital Healthcare Fund LP | Feb 17 | Feb 17 | A | 35,868 | $27.88 | $1,000,000 | 2,710,293 | No | Form 4 |
| Hopfner Robert Lorne | Dec 19, 2025 | Dec 22, 2025 | P | 1,000 | $17.35 | Purchase +$17,350 | 4,026 | No | Form 4 |
| Bauer EugeneChief Medical Officer | Dec 8, 2025 | Dec 19, 2025 | A · derivative | 100,000 | $18.44 | $1,844,000 | 100,000 | No | Form 4 |
| Pena Luis C.President & CEO | Dec 9, 2025 | Dec 11, 2025 | F | 28,138 | $17.84 | $501,982 | 654,683 | No | Form 4 |
| Bauer EugeneChief Medical Officer | Dec 9, 2025 | Dec 11, 2025 | F | 1,478 | $17.84 | $26,368 | 270,818 | No | Form 4 |
| Moss Gregory S.Chief Business & Legal Officer | Dec 9, 2025 | Dec 11, 2025 | F | 13,624 | $17.84 | $243,052 | 60,835 | No | Form 4 |
| Carver KyleChief Financial Officer | Dec 9, 2025 | Dec 11, 2025 | F | 13,290 | $17.84 | $237,094 | 62,510 | No | Form 4 |
| Drew Janice SuzannEVP, Operations | Dec 9, 2025 | Dec 11, 2025 | F | 5,074 | $17.84 | $90,520 | 67,794 | No | Form 4 |
| Patel Jeegar PravinkumarChief Scientific Officer | Dec 9, 2025 | Dec 11, 2025 | F | 7,513 | $17.84 | $134,032 | 49,578 | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C | 1,441,032 | not reported | not reported | 1,441,032 | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C | 1,632,441 | not reported | not reported | 1,632,441 | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C | 294,502 | not reported | not reported | 294,502 | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 7,145,647 | not reported | not reported | not reported | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 3,572,816 | not reported | not reported | not reported | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 2,582,243 | not reported | not reported | not reported | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 7,230,283 | not reported | not reported | not reported | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 1,895,260 | not reported | not reported | not reported | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 2,104,740 | not reported | not reported | not reported | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 313,571 | not reported | not reported | not reported | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 313,571 | not reported | not reported | not reported | No | Form 4 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 2,508,575 | not reported | not reported | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Nov 7, 2025 | Nov 12, 2025 | C | 1,517,329 | not reported | not reported | 1,517,329 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 7, 2025 | Nov 12, 2025 | C | 691,441 | not reported | not reported | 691,441 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 7, 2025 | Nov 12, 2025 | P | 1,157,096 | $16.00 | Purchase +$18,513,536 | 2,674,425 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 7, 2025 | Nov 12, 2025 | P | 92,904 | $16.00 | Purchase +$1,486,464 | 784,345 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 12,924,620 | not reported | not reported | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 5,889,699 | not reported | not reported | not reported | No | Form 4 |
| Cohen David E | Nov 7, 2025 | Nov 12, 2025 | C | 6,056 | not reported | not reported | 23,665 | No | Form 4 |
| Cohen David E | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 51,588 | not reported | not reported | not reported | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C | 3,026 | not reported | not reported | 3,026 | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C | 1,441,032 | not reported | not reported | 1,441,032 | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C | 1,632,441 | not reported | not reported | 1,632,441 | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C | 294,502 | not reported | not reported | 294,502 | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 25,790 | not reported | not reported | not reported | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 7,145,647 | not reported | not reported | not reported | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 3,572,816 | not reported | not reported | not reported | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 2,582,243 | not reported | not reported | not reported | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 7,230,283 | not reported | not reported | not reported | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 1,895,260 | not reported | not reported | not reported | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 2,104,740 | not reported | not reported | not reported | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 313,571 | not reported | not reported | not reported | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 313,571 | not reported | not reported | not reported | No | Form 4 |
| Hopfner Robert Lorne | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 2,508,575 | not reported | not reported | not reported | No | Form 4 |
| Pena Luis C.President & CEO | Nov 7, 2025 | Nov 12, 2025 | C | 24,225 | not reported | not reported | 682,821 | No | Form 4 |
| Pena Luis C.President & CEO | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 206,355 | not reported | not reported | not reported | No | Form 4 |
| Bauer EugeneChief Medical Officer | Nov 7, 2025 | Nov 12, 2025 | C | 25,812 | not reported | not reported | 272,296 | No | Form 4 |
| Bauer EugeneChief Medical Officer | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 206,355 | not reported | not reported | not reported | No | Form 4 |
| Bauer EugeneChief Medical Officer | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 12,500 | not reported | not reported | not reported | No | Form 4 |
| Moss Gregory S.Chief Business & Legal Officer | Nov 7, 2025 | Nov 12, 2025 | C | 3,175 | not reported | not reported | 3,175 | No | Form 4 |
| Moss Gregory S.Chief Business & Legal Officer | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 25,000 | not reported | not reported | not reported | No | Form 4 |
| Carver KyleChief Financial Officer | Nov 7, 2025 | Nov 12, 2025 | C | 3,175 | not reported | not reported | 75,800 | No | Form 4 |
| Carver KyleChief Financial Officer | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 25,000 | not reported | not reported | not reported | No | Form 4 |
| LSP 7 Cooperative UA | Nov 7, 2025 | Nov 12, 2025 | C | 3,367,133 | not reported | not reported | 3,367,133 | No | Form 4 |
| LSP 7 Cooperative UA | Nov 7, 2025 | Nov 12, 2025 | P | 1,562,500 | $16.00 | Purchase +$25,000,000 | 4,929,633 | No | Form 4 |
| LSP 7 Cooperative UA | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 15,493,466 | not reported | not reported | not reported | No | Form 4 |
| LSP 7 Cooperative UA | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 5,090,000 | not reported | not reported | not reported | No | Form 4 |
| LSP 7 Cooperative UA | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 6,585,011 | not reported | not reported | not reported | No | Form 4 |
| Drew Janice SuzannEVP, Operations | Nov 7, 2025 | Nov 12, 2025 | C | 1,587 | not reported | not reported | 72,868 | No | Form 4 |
| Drew Janice SuzannEVP, Operations | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 12,500 | not reported | not reported | not reported | No | Form 4 |
| Patel Jeegar PravinkumarChief Scientific Officer | Nov 7, 2025 | Nov 12, 2025 | C | 3,175 | not reported | not reported | 57,091 | No | Form 4 |
| Patel Jeegar PravinkumarChief Scientific Officer | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 25,000 | not reported | not reported | not reported | No | Form 4 |
| Verduyn-van Weegen Felice Isabel | Nov 7, 2025 | Nov 12, 2025 | C | 3,367,133 | not reported | not reported | 3,367,133 | No | Form 4 |
| Verduyn-van Weegen Felice Isabel | Nov 7, 2025 | Nov 12, 2025 | P | 1,562,500 | $16.00 | Purchase +$25,000,000 | 4,929,633 | No | Form 4 |
| Verduyn-van Weegen Felice Isabel | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 15,493,466 | not reported | not reported | not reported | No | Form 4 |
| Verduyn-van Weegen Felice Isabel | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 5,090,000 | not reported | not reported | not reported | No | Form 4 |
| Verduyn-van Weegen Felice Isabel | Nov 7, 2025 | Nov 12, 2025 | C · derivative | 6,585,011 | not reported | not reported | not reported | No | Form 4 |
| Mcgraw Benjamin F III | Nov 5, 2025 | Nov 7, 2025 | A · derivative | 37,960 | $16.00 | $607,360 | 37,960 | No | Form 4 |
| Kirsch Arthur S | Nov 5, 2025 | Nov 7, 2025 | A · derivative | 37,960 | $16.00 | $607,360 | 37,960 | No | Form 4 |
| Cohen David E | Nov 5, 2025 | Nov 7, 2025 | A · derivative | 37,960 | $16.00 | $607,360 | 37,960 | No | Form 4 |
| Pena Luis C.President & CEO | Nov 5, 2025 | Nov 7, 2025 | A · derivative | 796,841 | $16.00 | $12,749,456 | 796,841 | No | Form 4 |
| Moss Gregory S.Chief Business & Legal Officer | Nov 5, 2025 | Nov 7, 2025 | A · derivative | 293,496 | $16.00 | $4,695,936 | 293,496 | No | Form 4 |
| Carver KyleChief Financial Officer | Nov 5, 2025 | Nov 7, 2025 | A · derivative | 279,408 | $16.00 | $4,470,528 | 279,408 | No | Form 4 |
| Drew Janice SuzannEVP, Operations | Nov 5, 2025 | Nov 7, 2025 | A · derivative | 231,274 | $16.00 | $3,700,384 | 231,274 | No | Form 4 |
| Patel Jeegar PravinkumarChief Scientific Officer | Nov 5, 2025 | Nov 7, 2025 | A · derivative | 179,619 | $16.00 | $2,873,904 | 179,619 | No | Form 4 |